Lv2
160 积分 2021-09-28 加入
Genomic Characteristics and Single-Cell Profiles After Immunotherapy in Fumarate Hydratase-Deficient Renal Cell Carcinoma
3天前
已完结
Targeting Tumor-Associated Macrophages and Cancer-Associated Fibroblasts to Overcome Therapeutic Resistance in Hepatocellular Carcinoma
5天前
已完结
Molecular and therapeutic landscape of non-clear cell renal carcinoma
6天前
已完结
The Promise of Neoadjuvant and Adjuvant Therapies for Renal Cancer
1个月前
已完结
Delphi consensus on stereotactic ablative radiotherapy for oligometastatic and oligoprogressive renal cell carcinoma—a European Society for Radiotherapy and Oncology study endorsed by the European Association of Urology
4个月前
已完结
Disitamab Vedotin plus Toripalimab in HER2-Expressing Advanced Urothelial Cancer
4个月前
已完结
Efficacy and Safety of BL-B01D1 in Patients With Locally Advanced or Metastatic Urothelial Carcinoma: A Phase II Clinical Trial
4个月前
已完结
First-Line Therapy For Advanced Non–Clear Cell Renal Cell Carcinoma
7个月前
已完结
皖公网安备34019202002308
